Article Text
Letter
Anti-tumour necrosis factor α therapy modulates ghrelin in patients with severe rheumatoid arthritis
Statistics from Altmetric.com
Footnotes
MAGG and JL share senior authorship
Funding: This study was supported by a grant from Fondo de Investigaciones Sanitarias PI06-0024 (Spain).
Competing interests: Subsequent to this study, MAGG has accepted a role on the advisory board of Centocor. This study was not supported by any pharmaceatical company.
Ethics approval: Local institutional committee approval and patients’ informed consent was obtained.